Welcome to our dedicated page for Cemtrex SEC filings (Ticker: CETX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cemtrex Inc. filings document a public operating company with Security, Industrial, and Aerospace & Defense activities, including governance matters, capital-structure transactions, acquisitions, and material agreements. Proxy filings cover shareholder voting and corporate governance, while current reports record completed business acquisitions, registered direct offerings, common stock and pre-funded warrant issuances, and Series 1 Preferred Stock dividend treatment.
The filing record also includes acquisition disclosures for Invocon and Richland Industries, including asset or share purchase agreements, completion reports, financing arrangements, and related financial statement or pro forma information. These documents describe how acquired operations are incorporated into Cemtrex’s industrial services and aerospace-defense platforms, alongside the company’s ongoing securities and reporting obligations.
Cemtrex Inc. reported that its board of directors approved payment of the upcoming dividend on its Series 1 Preferred Stock in additional shares of the same Series 1 Preferred Stock rather than in cash. The new shares are expected to be issued on October 7, 2025 to holders of record as of the close of business on September 30, 2025.
Holders of the Series 1 Preferred Stock are entitled to receive dividends at a 10% annual rate, based on a $10.00 per share preference amount, with dividends payable on a semiannual schedule.
CEMTREX Inc. is the subject of a jointly filed Schedule 13G/A by three Altium-related reporting persons that discloses no reportable stake in the company’s common stock. The filing names Altium Healthcare Long Short Onshore Fund LP, Altium Capital Management LLC and Altium Healthcare Long Short GP LLC and states the Fund as the record and direct beneficial owner of the securities covered by the statement while simultaneously reporting an aggregate beneficial ownership of 0 shares (0% of the class). The filers note they may be deemed members of a group for regulatory purposes but expressly state the filing is not an admission of beneficial ownership or of acting to acquire or influence control. The statement also includes a certification that the securities were not acquired to influence control.
This Schedule 13G/A discloses that Mitchell P. Kopin, Daniel B. Asher and Intracoastal Capital LLC (the Reporting Persons) are each deemed to beneficially own 336,801 shares of Cemtrex Inc. common stock, representing approximately 9.99% of the company’s outstanding common stock as presented in the filing. The shares reported are issuable upon exercise of a warrant held by Intracoastal (Intracoastal Warrant 1).
Each Reporting Person has shared voting and shared dispositive power over 336,801 shares and no sole voting or dispositive power. The filing explains that blocker provisions in Intracoastal Warrant 1 and Intracoastal Warrant 2 prevent exercise to the extent doing so would increase ownership above 9.99% and 4.99%, respectively, thereby excluding 1,671,598 and 142,778 warrant shares from current beneficial ownership calculations. Without those blocker provisions, the Reporting Persons may be deemed to beneficially own 2,151,177 shares.